Pnc Financial Services Group, Inc. Vyne Therapeutics Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.5 - $1.15 $1,000 - $2,300	-2,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.91 - $1.5 $1,820 - $3,000	2,000 New	2,000 $2,000
Q3 2021 Nov 05, 2021	SELL	$1.39 - $3.47 $94 - $235	-68 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$6.34 - $12.68 $431 - $862	68 New	68 $0

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $184M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.